In addition, inactivating mutations in CREBBP, which encodes the important GR transcriptional coactivator CBP, have been detected in relapsed ALL, and impair GC-induced transcriptional responses[187]. This evidence concerns the gene NR3C1 and acute lymphoblastic leukemia.